We first tested the expression levels of HOXA-AS3 in five cell lines [four pancreatic cancer cell lines (Panc-1, Bxpc-3, Aspc-1, and Sw1990)] and one normal pancreatic dutal cell (HPDE) (Figure 2A) and found that the expressions of HOXA-AS3 were relatively higher in pancreatic cancer cell lines. This evidence concerns the gene HOXA-AS3 and pancreatic neoplasm.